Experimental Virology

Viruses are vehicles which transmit biological information, reprogramming the function of human, animal or plant cells to produce progeny virions. Viral pathogens are very small, often with a very simple structure. Indeed, enveloped viruses are composed only of a protein shell filled with genetic material, surrounded by a lipid envelope decorated with viral proteins. Nevertheless, viral pathogens like HIV or the hepatitis C virus (HCV) threaten the health of many millions of individuals.  Important human pathogens among the group of RNA viruses include besides HCV alsothe respiratory syncytial virus (RSV) and Chikunguna virus (CHIKV).

The institute comprises two research groups that focus on hepatitis viruses (HCV, HEV), RSV and CHIKV. 

Due to increasing travel restrictions the ACHIEVE Academy Workshop "Stepping stone to an academic career in virology" cannot take place as planned and unfortunately has to be cancelled. Furthermore, the networking event during the GfV Annual Meeting is cancelled.

We are currently evaluating whether the workshop can take place at a later timepoint.

News

24. June 2020

New research group “Computational Virology” at TWINCORE

Group leader Chris Lauber funded by RESIST


07. May 2020

Fraunhofer Research consortium iCAIR® makes use of synergies to develop new medications against SARS-CoV-2

With its rapid spread around the world, the new coronavirus SARS-CoV-2 has triggered a public health emergency of international concern. To date, there is neither a vaccine nor drugs for treating COVID-19 patients available....


24. April 2020

Searching for drugs against SARS-CoV-2

RESIST-Scientist Professor Pietschmann, head of the TWINCORE Insitute for Experimental Virology, leads the German part of an international consortium of scientists. This research network is searching for substances that act...


31. March 2020

Research projects on SARS-CoV-2 at TWINCORE

Activities concerning novel coronavirus have begun